Guinea vs Madagascar: The number of people with susceptibility test result for rifampicin
Guinea
4,242
in 2021
Madagascar
4,142
in 2021
Guinea rank
33rd
Madagascar rank
35th
The number of people with susceptibility test result for rifampicin over time
- Guinea
- Madagascar
How they compare
Guinea currently reports 4,242 against 4,142 in Madagascar, a difference of 100.
Across all 5 years both countries report, Guinea has been ahead every year.
Guinea ranks 33rd and Madagascar ranks 35th of 155 countries.
Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,430 | 2.67 | 1,427 | Guinea |
| 2020s | 2,200 | 2,074 | 126.5 | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guinea or Madagascar?
- Guinea, at 4,242 against 4,142 in Madagascar as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guinea and Madagascar?
- 100, with Guinea ahead.
- How many years of comparable data are there for Guinea and Madagascar?
- 5 years are reported by both, from 2017 to 2021.
- How do Guinea and Madagascar rank globally for the number of people with susceptibility test result for rifampicin?
- Guinea ranks 33rd and Madagascar ranks 35th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.